Page last updated: 2024-11-01

norfloxacin and Angioblastic Meningioma

norfloxacin has been researched along with Angioblastic Meningioma in 1 studies

Norfloxacin: A synthetic fluoroquinolone (FLUOROQUINOLONES) with broad-spectrum antibacterial activity against most gram-negative and gram-positive bacteria. Norfloxacin inhibits bacterial DNA GYRASE.
norfloxacin : A quinolinemonocarboxylic acid with broad-spectrum antibacterial activity against most gram-negative and gram-positive bacteria. Norfloxacin is bactericidal and its mode of action depends on blocking of bacterial DNA replication by binding itself to an enzyme called DNA gyrase.

Research Excerpts

ExcerptRelevanceReference
"The authors report on a case of tamoxifen/norfloxacin interaction leading to QT interval prolongation in an 83-year-old female patient with extracranial meningioma treated with radiation and hormonal therapy (with Tamoxifen)."7.77Tamoxifen/norfloxacin interaction leading to QT interval prolongation in a female patient with extracranial meningioma. ( Kopecky, J; Petera, J; Priester, P; Slanska, I; Slovacek, L, 2011)
"The authors report on a case of tamoxifen/norfloxacin interaction leading to QT interval prolongation in an 83-year-old female patient with extracranial meningioma treated with radiation and hormonal therapy (with Tamoxifen)."3.77Tamoxifen/norfloxacin interaction leading to QT interval prolongation in a female patient with extracranial meningioma. ( Kopecky, J; Petera, J; Priester, P; Slanska, I; Slovacek, L, 2011)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Slovacek, L1
Priester, P1
Petera, J1
Slanska, I1
Kopecky, J1

Other Studies

1 other study available for norfloxacin and Angioblastic Meningioma

ArticleYear
Tamoxifen/norfloxacin interaction leading to QT interval prolongation in a female patient with extracranial meningioma.
    Bratislavske lekarske listy, 2011, Volume: 112, Issue:6

    Topics: Aged, 80 and over; Anti-Bacterial Agents; Antineoplastic Agents, Hormonal; Drug Interactions; Female

2011